Chembio Diagnostics Inc develops, manufactures, and commercializes point of care diagnostic tests that detect infectious diseases. Its products are rapid tests for the detection of HIV 1/2 antibodies, and for the detection of HIV and Syphilis antibodies.
| Website: | www.chembio.com |
| Email: | snorcott@chembio.com |
| Main Phone: | +1 631 924-1135 |
| Address: | 3661 Horseblock Road |
| State: | NY |
| City / Town: | Medford |
| Country: | USA |
| Postal Code: | 11763 |
| Exchange: | NSC |
| CEO: | John J. Sperzel |
| Employees: | 165 |
| NAICS: | In-Vitro Diagnostic Substance Manufacturing(325413) |
| Last Price 9.85 | Change $ 0. | Change % 0.00 | Tick N/A |
| Bid 9.35 | Bid Size 400.00 | Ask 12.35 | Ask Size 9,800.00 |
| Open 9.76 | High 9.85 | Low 9.70 | Prev Close 9.85 |
| Last Trade | Volume 21,141 | 52 Wk Hi 11.55 | 52 Wk Low 5.75 |
| Market Cap 139.6 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 14,173,620.00 | EPS (TTM) -0.38 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 7 | 19 |
| Number of Buys | 2 | 6 |
| Number of Sells | 5 | 13 |
| Net Activity | -14082 | 5304 |
| Last 10 Buys | Shares |
|---|---|
| Neil A. Goldman | 1,000 |
| Peter T. Kissinger | 1,000 |
| Sharon Klugewicz | 1,000 |
| Gary Meller | 1,000 |
| Katherine L. Davis | 1,000 |
| Katherine L. Davis | 1,000 |
| Gary Meller | 1,000 |
| Katherine L. Davis | 1,000 |
| Katherine L. Davis | 1,000 |
| Katherine L. Davis | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Sharon Klugewicz | 1,000 |
| Javan Esfandiari | 1,000 |
| Javan Esfandiari | 1,000 |
| Javan Esfandiari | 1,000 |
| Richard J. Larkin | 1,000 |
| Javan Esfandiari | 1,000 |
| Javan Esfandiari | 1,000 |
| Lawrence A. Siebert | 1,000 |
| Lawrence A. Siebert | 1,000 |
| Lawrence A. Siebert | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 13.5 | 13.5 | 13.5 | 13.5 |
| Low Target Price Estimate | 10 | 10 | 10 | 10 |
| Mean Target Price Estimate | 11.17 | 11.17 | 11.17 | 11.17 |
| Standard Deviation | 2.02 | 2.02 | 2.02 | 2.02 |
| Date of Most Recent Estimate | 05/15/18 | 05/15/18 | 05/15/18 | 05/15/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 23 | 2018-05-30 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2018-05-25 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-16 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2018-05-16 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2018-05-09 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 32 | 2018-05-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-04-27 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2018-04-26 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
